Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Senores Pharmaceuticals Ltd.
₹1,160
₹1115.35
₹1160.00
₹500.00
₹1194.40
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 36.81 | 28.76 | 35.33 | 19.82 | 11.86 |
| Operating Expense | 40.29 | 29.69 | 33.81 | 20.97 | 14.60 |
| Operating Profit | -3.48 | -0.93 | 1.52 | -1.15 | -2.74 |
| Depreciation | 4.13 | 3.58 | 3.65 | 1.88 | 1.27 |
| Interest | 1.89 | 1.75 | 1.58 | 1.76 | 2.35 |
| Tax | 4.21 | 0.87 | 1.22 | 0.90 | 0.88 |
| Net Profit | 8.48 | 2.65 | 6.43 | 2.70 | 2.01 |
₹1160.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 45.8 | 45.8 | 45.8 | 45.8 | 45.8 | 45.8 |
| FII | 4.2 | 4.2 | 3.7 | 4.3 | 3.4 | 3.6 |
| DII | 11.8 | 9.6 | 9.5 | 8.6 | 9.3 | 9.7 |
| Public | 38.2 | 40.4 | 41 | 41.3 | 41.5 | 40.9 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.14 L | 6.46 L | 33.15% |
| Week | 4.5 L | 17.89 L | 25.15% |
| 1 Month | 2.35 L | 6.59 L | 35.58% |
| 6 Month | 1.42 L | 3.32 L | 42.82% |
High DVM Mid and Small Caps (subscription)
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,681.10 | ₹696 | ₹943.35 | ₹4,620 | ₹521.20 |
| % Change | -0.21% | 3.36% | -0.67% | -2.43% | 0.22% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | - | ₹1,598.19 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | - | ₹206.20 | ₹257.90 | ₹255.19 |
| PE TTM | 57.20 | - | 78.90 | 43.40 | 31.80 |
| 1 Year Return | 63.07 | 9.63 | 103.31 | -2.21 | -6.77 |
| ROCE | 31.54 | 34.78 | 34.76 | - | 11.40 |
Blue Jet Healthcare Ltd
₹ 483.95
+9.73%
Concord Biotech Ltd.
₹ 1131.20
-1.92%
Aarti Pharmalabs Ltd.
₹ 735.45
+3.13%
Supriya Lifescience Ltd.
₹ 765.65
-1.09%
Alivus Life Sciences Ltd.
₹ 1059.90
+2.01%
Cohance Lifesciences Ltd.
₹ 435.50
+4.05%
Eris Lifesciences Ltd.
₹ 1353.40
+0.71%
Syngene International Ltd.
₹ 462.45
+0.13%
Sun Pharma Advanced Research Company Ltd.
₹ 235.80
+12.41%
Strides Pharma Science Ltd.
₹ 1185.00
+2.76%
Granules India Ltd.
₹ 760.40
+1.12%
FDC Ltd.
₹ 369.00
-1.14%
Shilpa Medicare Ltd.
₹ 514.60
+4.97%
Jubilant Pharmova Ltd.
₹ 995.10
-1.12%
Caplin Point Laboratories Ltd.
₹ 2082.00
+2.66%
Marksans Pharma Ltd.
₹ 220.55
+4.10%
Sanofi India Ltd.
₹ 3179.00
+0.50%
Procter & Gamble Health Ltd.
₹ 5741.00
+3.39%
Jeena Sikho Lifecare Ltd.
₹ 635.00
-2.27%
By signing up I certify terms, conditions & privacy policy